Aflofarm’s Maxicortan switched from Rx to OTC
…of atopic dermatitis, allergic eczema/urticaria and reactions to insect bites. The reclassification took effect immediately. The Marketing Authorisation Holder (MAH) is Aflofarm. This is the fourth Rx-OTC switch this year, as opposed to 12 in 2018, according to PMR data.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)